Depressive therapy Spravato demonstrates superior efficacy
Research supports use of Spravato nasal spray in adults with major depressive disorder
Read More
Tag: efficacy
Rivus presents results from trial evaluating controlled metabolic accelerator
HU6 data demonstrates significant selective weight loss across all body compartments
Read More
Aimovig shows long-term efficacy where other treatments fail
The STRIVE data will be presented at the European Academy of Neurology (EAN) annual meeting in Oslo, Norway.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
